Oral herpes drug developer Squarex Pharmaceuticals files for $15M IPO
anotherperfectday Squarex Pharmaceuticals (SQRX) has filed to raise $15M through an initial public offering to help fund development of its product to prevent cold sore outbreaks. The biotech company didn't specify in its filing how many shares it intended to...